VUKE:LSE-Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF (GBX)

ETF | Others | LSE

Last Closing Price

GBX 31.39

Change

0.00 (0.00)%

Market Cap

GBX 3.55B

Volume

0.30M

Avg Analyst Target

N/A

Avg User Target

GBX
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF (VUKE) Stock Analysis:
Based on the Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF stock forecasts from 0 analysts, the average analyst target price for Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF is not available over the next 12 months. Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF is Slightly Bullish , which is based on 3 positive signals and 2 negative signals. At the last closing, Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF’s stock price was GBX 31.39. Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF’s stock price has changed by +0.33 % over the past week, -3,170.12 % over the past month and +7.93 % over the last year.

About

This Fund seeks to track the performance of the Index, a widely recognised UK benchmark of the UK market?s most highly capitalised blue chip companies. The Fund employs a ?passive management?? or indexing ? investment approach, through physical acquisition of securities, designed ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Vanguard Funds Public Limited Company - Vanguard FTSE 100 UCITS ETF Allocation
AZN 7.18 %
UL 5.15 %
HSBC 4.60 %
DEO 4.25 %
GSK 3.80 %
BP 3.55 %
RDS-A 3.19 %
BTI 2.96 %
RIO 2.53 %
GLCNF 2.47 %
Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-07 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
0Q1N:LSE Pfizer Inc. 0.00 %

-0.59 (-1.11%)

GBX244.23B
BOI:LSE Bank Of Ireland Group plc 13.3.. 0.00 %

N/A

GBX238.29B
XDJP:LSE Xtrackers - Nikkei 225 UCITS E.. 0.09 %

+50.00 (+2.58%)

GBX197.24B
LCJD:LSE Multi Units Luxembourg - Lyxor.. 0.12 %

+0.36 (+2.20%)

GBX183.42B
LCJP:LSE Multi Units Luxembourg - Lyxor.. 0.12 %

+0.31 (+2.48%)

GBX183.42B
LLPD:LSE Lloyds Banking Group PLC 9.75%.. 0.00 %

N/A

GBX122.54B
LLPC:LSE Lloyds Banking Group PLC 9.25%.. 0.00 %

N/A

GBX117.03B
UC65:LSE UBS (Lux) Fund Solutions - MSC.. 0.19 %

+0.45 (+0.84%)

GBX105.92B
UB02:LSE UBS (Lux) Fund Solutions - MSC.. 0.00 %

+85.91 (+2.15%)

GBX105.92B
JPSR:LSE UBS (Lux) Fund Solutions - MSC.. 0.22 %

+31.50 (+1.60%)

GBX92.19B

ETFs Containing VUKE

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.93% 48% F 48% F
Dividend Return 2.69% 89% B+ 89% B+
Total Return 12.62% 53% F 52% F
Trailing 12 Months  
Capital Gain 7.93% 44% F 43% F
Dividend Return 2.64% 88% B+ 86% B
Total Return 10.57% 47% F 45% F
Trailing 5 Years  
Capital Gain 1.20% 22% F 34% F
Dividend Return 16.26% 87% B+ 71% C-
Total Return 17.46% 34% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 789.64% 97% A+ 98% A+
Dividend Return 2.94% 89% B+ 36% F
Total Return 792.58% 97% A+ 98% A+
Risk Return Profile  
Volatility (Standard Deviation) 2,939.67% 3% F 2% F
Risk Adjusted Return 26.96% 36% F 46% F
Market Capitalization 3.55B 92% A- 81% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.